Recent News and Articles on the Keywords: news + releases + 2007 Related to the article below (Last Update: 8/5/2008)
Kimberley Process Releases 2007 Statistical Data IDEX Online, Israel - 13 minutes ago Global diamond production decreased by 3.88 percent in 2007, according to recently published statistical data on diamond output, exports and imports in 2007...
CAMVAP releases 2007 arbitration data CanadianDriver, Canada - Toronto, Ontario - The Canadian Motor Vehicle Arbitration Plan (CAMVAP) has released its 2007 annual report, which showed that in that year, the arbitrators ...
Havertys Reports Results for Second Quarter 2008 MarketWatch - News releases include forward-looking statements, which are subject to risks and uncertainties. Factors that might cause actual results to differ materially ...HVT - OTC:CMTX
Aliant releases 2007 Sustainability Report Canada NewsWire (press release), Canada - Jul 31, 2008 Here are highlights from the environmental section of the 2007 Aliant Sustainability Report: << - Over 22000 megawatts of power were saved; this is roughly ...TSE:BA.UN
AGlobal International releases its prediction on 2008 US ... PR Web (press release), WA - ... of its latest series of articles on US Presidential Election 2008 Predictions (which was originally published on December 2007 from its former website). ...
Source: Google News
Large Shareholder Activism, Risk Sharing, and Financial Market Equilibrium - AR Admati, P Pfleiderer, J Zechner - Journal of Political Economy, 1994 - UChicago Press ... (2007) Insider Trading, NewsReleases, and Ownership Concentration. The Journal
of Finance 61:6, 2931-2973 Online publication date: 1-Jan-2007. ...
Insider Trading: Should It Be Prohibited? - HE Leland - Journal of Political Economy, 1992 - UChicago Press ... (2007) Insider Trading, NewsReleases, and Ownership Concentration. The Journal
of Finance 61:6, 2931-2973 Online publication date: 1-Jan-2007. ...
Financial Development, Growth, and the Distribution of Income - J Greenwood, B Jovanovic - Journal of Political Economy, 1990 - UChicago Press ... full press release. >> Go to press release archive. In the News. Featured in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
Industrial Development in Cities - V Henderson, A Kuncoro, M Turner - Journal of Political Economy, 1995 - UChicago Press ... Read full press release. >> Go to press release archive. In the News. ... in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
On the Interaction between the Quantity and Quality of Children - GS Becker, HG Lewis - Journal of Political Economy, 1973 - UChicago Press ... full press release. >> Go to press release archive. In the News. Featured in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
Exchange Rate Dynamics Redux - M Obstfeld, K Rogoff - Journal of Political Economy, 1995 - UChicago Press ... Read full press release. >> Go to press release archive. In the News. ... in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
Occupational Choice and the Process of Development - AV Banerjee, AF Newman - Journal of Political Economy, 1993 - UChicago Press ... Read full press release. >> Go to press release archive. In the News. ... in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
Money-Wage Dynamics and Labor-Market Equilibrium - ES Phelps - Journal of Political Economy, 1968 - UChicago Press ... Read full press release. >> Go to press release archive. In the News. ... in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
How Does Privatization Work? Evidence from the Russian Shops - N Barberis, M Boycko, A Shleifer, N Tsukanova - Journal of Political Economy, 1996 - UChicago Press ... full press release. >> Go to press release archive. In the News. Featured in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
Barriers to Technology Adoption and Development - SL Parente, EC Prescott - Journal of Political Economy, 1994 - UChicago Press ... Read full press release. >> Go to press release archive. In the News. ... in National
Public Radio "Thank You for Advertising" August 10, 2007 Private Profits and ...
Source: Google Scholar
Moderate Drinking May Lower Kidney Cancer Risk
But alcohol can raise odds for other malignancies, researchers warn
(SOURCE: Brigham and Women's Hospital, news release, May 15, 2007)
THURSDAY, May 17 (HealthDay News) -- Moderate drinking may lower the risk of a type of kidney malignancy called renal cell cancer, according to a review of data from 12 studies that included more than 750,000 people in five countries.
Researchers at Brigham and Women's Hospital in Boston concluded that women and men who drank an average of one alcoholic beverage a day were about 30 percent less likely to develop renal cell cancer than non-drinkers.
This reduced risk was seen in people who drank beer, wine or liquor. The findings are in the May 16 issue of the Journal of the National Cancer Institute.
Despite their review, the researchers stressed that not smoking and maintaining a healthy weight are the best ways to reduce the risk of renal cell cancer. They noted that alcohol raises the risk of cancers of the oral cavity, larynx, throat, esophagus, liver and breast, and possibly the colon and rectum.
Article continues below and (thank you)
"These healthy lifestyle choices (not smoking, weight control) should be encouraged, and doing so may also reduce the risk of many other cancers as well as cardiovascular disease," study author Jung Eun Lee said in a prepared statement.
More information
The U.S. National Cancer Institute has more about renal cell cancer.
General Information About Renal Cell Cancer
Key Points for This Section
Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney.
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Possible signs of renal cell cancer include blood in the urine and a lump in the abdomen.
Tests that examine the abdomen and kidneys are used to detect (find) and diagnose renal cell cancer.
Certain factors affect prognosis (chance of recovery) and treatment options.
Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney.
Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which malignant (cancer) cells are found in the lining of tubules (very small tubes) in the kidney. There are 2 kidneys, one on each side of the backbone, above the waist. The tiny tubules in the kidneys filter and clean the blood, taking out waste products and making urine. The urine passes from each kidney into the bladder through a long tube called a ureter. The bladder stores the urine until it is passed from the body.
Cancer that starts in the ureters or the renal pelvis (the part of the kidney that collects urine and drains it to the ureters) is different from renal cell cancer. Refer to the PDQ summary on Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment for more information).
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Risk factors include the following:
Smoking.
Misusing certain pain medicines, including over-the-counter pain medicines, for a long time.
Having certain genetic conditions, such as von Hippel-Lindau disease or hereditary papillary renal cell carcinoma.
Possible signs of renal cell cancer include blood in the urine and a lump in the abdomen.
These and other symptoms may be caused by renal cell cancer. Other conditions may cause the same symptoms. There may be no symptoms in the early stages. Symptoms may appear as the tumor grows. A doctor should be consulted if any of the following problems occur:
Blood in the urine.
A lump in the abdomen.
A pain in the side that doesn't go away.
Loss of appetite.
Weight loss for no known reason.
Anemia.
Tests that examine the abdomen and kidneys are used to detect (find) and diagnose renal cell cancer.
The following tests and procedures may be used:
Physical exam and history: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patient’s health habits and past illnesses and treatments will also be taken.
Blood chemistry studies: A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease in the organ or tissue that makes it.
Urinalysis: A test to check the color of urine and its contents, such as sugar, protein, red blood cells, and white blood cells.
Liver function test: A procedure in which a sample of blood is checked to measure the amounts of enzymes released into it by the liver. An abnormal amount of an enzyme can be a sign that cancer has spread to the liver. Certain conditions that are not cancer may also increase liver enzyme levels.
Intravenous pyelogram (IVP): A series of x-rays of the kidneys, ureters, and bladder to find out if cancer is present in these organs. A contrast dye is injected into a vein. As the contrast dye moves through the kidneys, ureters, and bladder, x-rays are taken to see if there are any blockages.
Ultrasound exam: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram.
CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.
MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).
Biopsy: The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. To do a biopsy for renal cell cancer, a thin needle is inserted into the tumor and a sample of tissue is withdrawn.
Certain factors affect prognosis (chance of recovery) and treatment options.
The prognosis (chance of recovery) and treatment options depend on the following:
The stage of the disease.
The patient's age and general health.
Pollutants, food ingredients, solvents may all cause harm, researchers say.
By Alan Mozes HealthDay Reporter
MONDAY, May 14 (HealthDay News) -- A detailed analysis of hundreds of completed breast cancer studies has linked disease development with environmental exposure to more than 200 chemical compounds.
The finding is part of an effort to build a free, online breast cancer database for researchers and the public.
Described as "the most comprehensive of its kind," the database will highlight growing concern about environmental carcinogens such as pollutants, food contaminants, and organic solvents. The scope of the project will also extend to work that explores risk-related lifestyle factors such as diet, levels of physical activity, smoking/drinking habits and body mass.
"This compilation is a great effort, because it summarizes all the evidence and gives us hints of what to look for next," explained researcher Leslie Bernstein, a professor of preventive medicine with the Keck School of Medicine at the University of Southern California in Los Angeles.
The results are outlined in a supplement to the May 14th online issue of Cancer. The database is already accessible at either www.silentspring.org/sciencereview or www.komen.org/environment.
According to the American Cancer Society (ACS), carcinogens are defined as agents that instigate abnormal cell division or harmful changes in the structure of a cell's DNA. They include chemicals, radiation, or infectious agents, among other things.
The ACS also notes that with the exception of skin cancer, breast cancer is the most common cancer among American women. This year, almost 179,000 women in the United States will be diagnosed with the disease, and about 40,000 will die.
The International Agency of Research on Cancer has already classified 90 or so compounds as human carcinogens, according to the ACS. But Bernstein's team said that most of the chemicals to which people are routinely exposed have not undergone any testing for carcinogenic risk. An estimated 80,000 chemicals are registered in the United States for commercial use, according to the researchers.
For more than two years, Bernstein worked alongside colleagues from Harvard University, the Roswell Park Cancer Institute, and the Silent Spring Institute to amass and sort through approximately 900 national and international breast cancer studies focused on carcinogens.
The team honed in on 460 human breast cancer studies, of which more than 150 looked at specific environmental carcinogens among breast cancer patients. Most of those studies were conducted in the 1990s.
The remaining studies involved animal or laboratory research. The researchers pointed out that animal studies are valid references, because all known human carcinogens have also triggered tumors in animal subjects.
In the animal studies alone, evidence surfaced that linked 216 chemicals to the onset of breast tumors. These included 36 industrial chemicals, 6 chlorinated solvents, 18 products of combustion, 10 pesticides, 18 dyes, four type of radiation, 47 pharmaceuticals, and 17 hormones.
Of these compounds, the researchers isolated 73 that can be found in either human food or consumer products.
They noted, for example, the lingering hazards associated with polychlorinated biphenyls (or PCBs), which were typically used in the production of electrical equipment until federally banned in 1979. PCBs continue to pose a risk via contaminated rivers, fish, and pre-existing building construction, the researchers warned.
In addition, the authors categorized 35 compounds as carcinogenic air pollutants, including polycyclic aromatic hydrocarbons (or PAHs), which are byproducts of combustion.
The team also drew attention to another group of 25 organic compounds, including dioxins, which are produced by waste incineration and manufacturing. These carcinogenic chemicals are present in many American workplaces and place more than 5,000 women at an increased risk for breast cancer, the researchers said. These include women working in machine shops, dry cleaners, hairdressers, glass manufacturers, and aircraft maintenance facilities, all of which use harmful organic solvents.
Furthermore, among the identified carcinogens, 29 are produced in large amounts -- upwards of one million pounds or more per year.
The database project did not set strict guidelines as to how to limit exposure to carcinogens. But the authors said they encouraged research and government oversight into the problem. They advised that people do try and limit their exposure to PCB-contaminated fish, gasoline-generated air pollution, chlorinated tap water, non-stick coated cookware, and detergents containing fluorescent whiteners.
Just how carcinogenic, in terms of breast cancer risk, are these and other compounds on the list? The jury is still out on that question, Bernstein said.
"Women are terribly concerned about environmental causes of breast cancer," she said. "But it's really very difficult to study. Often the only way we've been able to look at some of these things is during occupational exposures or accidents -- what we usually call disasters."
"So, this work is a very useful tool for those of us who want to try to understand what we've missed in breast cancer. Now, it's up to us to do something with all this information," Bernstein said.
Janet Gray, a professor of psychology and the director of the program in science, technology and society at Vassar College in Poughkeepsie, N.Y., called the new database "an enormous contribution."
"Its greatest value is just the sheer comprehensive nature of the work, which allows both the public and researchers to have access to huge amounts of information in one place," she said. "I think this effort will really move us forward."
Known and Probable Carcinogens
Including Industrial Processes, Occupational Exposures, Infectious Agents, Chemicals, and Radiation)
What Is a Carcinogen?
Cancer is caused by abnormalities in a cell’s DNA (its genetic "blueprint"). These may be inherited from parents, or they may be caused by outside exposures to the body such as chemicals, radiation, or even infectious agents.
Substances that can cause changes that can lead to cancer are called carcinogens. Some carcinogens do not act on DNA directly, but lead to cancer in other ways, such as causing cells to divide at a faster rate, which could increase the chances that DNA changes will occur.
Carcinogens do not cause cancer in every case, all the time. Substances classified as carcinogens may have different levels of cancer-causing potential. Some may cause cancer only after prolonged, high levels of exposure. And for any particular person, the risk of developing cancer depends on many factors, including the length and intensity of exposure to the carcinogen and the person’s genetic makeup.
How Do We Determine if Something Is a Carcinogen? Scientists get much of their data about whether something might cause cancer from laboratory (cell culture and animal) studies. Although it isn’t possible to predict with certainty which substances will cause cancer in humans based on animal studies alone, virtually all known human carcinogens that have been adequately tested produce cancer in lab animals. In many cases, carcinogens are first found to cause cancer in lab animals and are later found to cause cancer in people. Because there are far too many substances (natural and manmade) to test each one in lab animals, scientists use knowledge about chemical structure, other types of lab tests, and information about the extent of human exposure to select chemicals for testing.
Most studies of potential carcinogens expose the lab animals to doses that are higher than common human exposures. This is so that cancer risk can be detected in relatively small groups of animals. For most carcinogens, it is assumed that those that cause cancer at larger doses in animals will also cause cancer in people. Although it isn’t always possible to know the relationship between exposure dose and risk, it is reasonable for public health purposes to assume that lowering human exposure will reduce risk.
Another important way to identify carcinogens is through epidemiologic studies, which look at human populations to determine which factors might be linked to cancer. While these studies also provide useful information, they also have their limitations. Humans do not live in a controlled environment. People are exposed to numerous substances at any one time, including those they encounter at work, school, or home; in the food they eat; and the air they breathe. And it is usually many years (often decades) between exposure to a carcinogen and the development of cancer. Therefore, it can be very hard to single out any particular exposure as having a definite link to cancer.
By combining data from both types of studies, scientists are able to make an educated assessment of a substance’s cancer-causing ability. When the available evidence is compelling but not felt to be conclusive, the substance may be considered to be a probable carcinogen.
How Are Carcinogens Classified?
International Agency for Research on Cancer (IARC)
The most widely used system for classifying carcinogens comes from the IARC, which is part if the World Health Organization (WHO). In the past 30 years, the IARC has evaluated the cancer-causing potential of about 900 likely candidates, placing them into one of the following groups:
Group 1: Carcinogenic to humans
Group 2A: Probably carcinogenic to humans
Group 2B: Possibly carcinogenic to humans
Group 3: Unclassifiable as to carcinogenicity in humans
Group 4: Probably not carcinogenic to humans
Perhaps not surprisingly, most of the agents are of probable, possible, or unknown risk. Only about 90 are classified as "carcinogenic to humans."
National Toxicology Program (NTP)
In the United States, the NTP releases the Report on Carcinogens about every 2 years. The NTP is formed from parts of several different government agencies, including the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA).
The Report on Carcinogens (RoC) identifies 2 groups of agents:
"Known to be human carcinogens"
"Reasonably anticipated to be human carcinogens"
Unlike the IARC’s list, the RoC does not list substances that have been studied and found not to be carcinogens. Below are the lists of known and probable human carcinogens from both groups.
Known Human Carcinogens
International Agency for Research on Cancer (IARC) "Carcinogenic to Humans" (Group 1)
Agents and Groups of Agents
Aflatoxins (naturally occurring mixtures of)
4-Aminobiphenyl
Arsenic and arsenic compounds (Note: This evaluation applies to the group of compounds as a whole and not necessarily to all individual compounds within the group)
Estrogens, nonsteroidal (Note: This evaluation applies to the group of compounds as a whole and not necessarily to all individual compounds within the group)
Estrogens, steroidal (Note: This evaluation applies to the group of compounds as a whole and not necessarily to all individual compounds within the group)
Ethylene oxide
Etoposide in combination with cisplatin and bleomycin
Formaldehyde
Gallium arsenide
Gamma radiation
Helicobacter pylori (infection with)
Hepatitis B virus (chronic infection with)
Hepatitis C virus (chronic infection with)
Herbal remedies containing plant species of the genus Aristolochia
Human immunodeficiency virus type 1 (infection with)
Human papillomavirus type 16
Human papillomavirus type 18
Human T-cell lymphotropic virus type I
Melphalan
8-Methoxypsoralen (Methoxsalen) plus ultraviolet A radiation
MOPP and other combined chemotherapy including alkylating agents
Mustard gas (Sulfur mustard)
2-Naphthylamine
Neutrons
Nickel compounds
Opisthorchis viverrini (infection with)
Oral contraceptives, combined (Note: There is also conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium)
Oral contraceptives, sequential
Phosphorus-32, as phosphate
Plutonium-239 and its decay products (may contain plutonium-240 and other isotopes), as aerosols
Radioiodines, short-lived isotopes, including iodine-131, from atomic reactor accidents and nuclear weapons detonation (exposure during childhood)
Radionuclides, alpha-particle-emitting, internally deposited (Note: Specific radionuclides for which there is sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents)
Radionuclides, beta-particle-emitting, internally deposited (Note: Specific radionuclides for which there is sufficient evidence for carcinogenicity to humans are also listed individually as Group 1 agents)
Radium-224 and its decay products
Radium-226 and its decay products
Radium-228 and its decay products
Radon-222 and its decay products
Schistosoma haematobium (infection with)
Silica, crystalline (inhaled in the form of quartz or cristobalite from occupational sources)
Solar radiation
Talc containing asbestiform fibers
Tamoxifen (Note: There is also conclusive evidence that this agent (tamoxifen) reduces the risk of contralateral breast cancer)
2,3,7,8-Tetrachlorodibenzo-para-dioxin
Thiotepa
Thorium-232 and its decay products, administered intravenously as a colloidal dispersion of thorium-232 dioxide
Treosulfan
Vinyl chloride
X- and Gamma radiation
Mixtures
Alcoholic beverages
Analgesic mixtures containing phenacetin
Areca nut
Betel quid with tobacco
Betel quid without tobacco
Coal-tar pitches
Coal-tars
Mineral oils, untreated and mildly treated
Salted fish (Chinese-style)
Shale-oils
Soots
Tobacco products, oral tobacco products
Wood dust
Exposure Circumstances
Aluminum production
Arsenic in drinking water
Auramine, manufacture of
Boot and shoe manufacture and repair
Coal gasification
Coke production
Furniture and cabinet making
Hematite mining (underground) with exposure to radon
